Mirvetuximab soravtansine (solution)
HY-132258A
Product group Antibodies
Overview
- SupplierMedChem Express
- Product NameMirvetuximab soravtansine (solution)
- Delivery Days Customer14
- CertificationResearch Use Only
- ClonalityMonoclonal
- Concentration10.246 mg/ml
- Estimated Purity99.71
- Scientific DescriptionMirvetuximab soravtansine (IMGN853) solution is an anti-folate receptor alpha ( FRalpha ) antibody drug-conjugate (ADC) consisting of the cytotoxic maytansinoid, DM4, covalently linked to the humanized monoclonal antibody M9346A. Mirvetuximab soravtansine selectively binds to folate receptor 1 (FOLR1). Mirvetuximab soravtansine has an anti-proliferative effect via growth arrest and augmented DNA damage [1] .
- Storage Instruction-80°C
- UNSPSC12352203